← Back to Search

Behavioral Intervention

Palliative Care Models for Critical Condition

N/A

Recruiting

Led By Scott Halpern, MD, PhD

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Age 18 years of age or older;

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up enrollment - 3 months post-discharge

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test the feasibility of providing palliative care to seriously ill patients in hospitals. The study involves enrolling 540 patients who have a high risk of dying within a year. The hospitals

Who is the study for?

This trial is for seriously ill hospitalized patients aged 18 or older, admitted to one of the study hospitals with a predicted mortality risk of at least 60% within the next year. It aims to improve their quality of life through palliative care.

What is being tested?

The study compares three approaches: usual care without specific PC training, generalist PC where hospital staff are trained online in palliative care, and specialist PC provided by experts. The goal is to see which model works best for patient support.

What are the potential side effects?

Since this trial focuses on models of care rather than medications, it does not have typical drug side effects. However, there may be differences in comfort levels or psychological impact based on the type of palliative care received.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ enrollment - 3 months post-discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~enrollment - 3 months post-discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment - 3 months post-discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Appropriate Firings of All Our Practice Advisory (OPA) Interventions

Secondary study objectives

Default Specialist PC Consults

Default Specialist PC Order Cancellation Rate

Generalist PC Domain Completion

+4 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Trained Generalist Palliative CareExperimental Treatment2 Interventions

Generalist clinicians trained in PC domains receive an EHR-based alert to document whether or not they have addressed PC domains for moderately high-risk patients ('accountable justification intervention'). A specialist PC consult is ordered by default for the highest-risk patients unless clinicians cancel the order.

Group II: Specialist Palliative CareExperimental Treatment1 Intervention

A specialist PC consult is ordered by default for all patients with a ≥ 60% 1-year mortality risk ('default order intervention'), unless clinicians cancel the order.

Group III: Standardized Usual CareActive Control1 Intervention

Active control group, where moderately high-risk patients (e.g., with a 1-year mortality risk between 60% and 94%) will receive usual care. A specialist PC consult is ordered by default for the highest-risk patients (i.e., 1-year mortality risk ≥ 95%), unless clinicians cancel the order.

0 / 1Eligibility criteria met